A Postmarket Registry of the BioMatrixâ„¢ and BioMatrix Flexâ„¢ Drug Eluting Stents.
A Postmarket Registry of the BioMatrixâ„¢ and BioMatrix Flexâ„¢ Drug Eluting Stents.
The purpose of this registry is to capture clinical data of the BioMatrixâ„¢ and BioMatrix Flexâ„¢ (Biolimus A9â„¢-Eluting) stent systems in relation to safety and effectiveness.
Prospective, multi-center registry to be conducted at 60-70 international interventional cardiology centers. All patients will be followed for up to 3 years.
Inclusion Criteria:
Exclusion Criteria: